TuHURA Net Income Per Share from 2010 to 2026

HURA Stock   1.25  0.04  3.10%   
TuHURA Biosciences' Net Loss is increasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to -1.1. From 2010 to 2026 TuHURA Biosciences Net Loss quarterly data regression line had arithmetic mean of (4,768) and significance of  0.04. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(1.05)
Current Value
(1.10)
Quarterly Volatility
6.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check TuHURA Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TuHURA Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 10.2 M, Total Operating Expenses of 10.2 M or Depreciation And Amortization of 140.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0187 or PTB Ratio of 4.94. TuHURA financial statements analysis is a perfect complement when working with TuHURA Biosciences Valuation or Volatility modules.
  
Build AI portfolio with TuHURA Stock
Check out the analysis of TuHURA Biosciences Correlation against competitors.
For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.
Analyzing TuHURA Biosciences's Net Income Per Share over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Per Share has evolved provides context for assessing TuHURA Biosciences's current valuation and future prospects.

Latest TuHURA Biosciences' Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of TuHURA Biosciences over the last few years. It is TuHURA Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TuHURA Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

TuHURA Net Income Per Share Regression Statistics

Arithmetic Mean(4,768)
Coefficient Of Variation(127.24)
Mean Deviation5,047
Median(1,529)
Standard Deviation6,067
Sample Variance36.8M
Range19.6K
R-Value0.50
Mean Square Error29.4M
R-Squared0.25
Significance0.04
Slope602.55
Total Sum of Squares589M

TuHURA Net Income Per Share History

2026 -1.1
2025 -1.05
2024 -1.16
2023 -38.94
2022 -202.39
2021 -252.13
2020 -2589.28

About TuHURA Biosciences Financial Statements

TuHURA Biosciences stakeholders use historical fundamental indicators, such as TuHURA Biosciences' Net Income Per Share, to determine how well the company is positioned to perform in the future. Although TuHURA Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in TuHURA Biosciences' assets and liabilities are reflected in the revenues and expenses on TuHURA Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in TuHURA Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss(1.05)(1.10)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:
Check out the analysis of TuHURA Biosciences Correlation against competitors.
For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. Market participants price TuHURA higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive TuHURA Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.74)
Return On Assets
(0.91)
Return On Equity
(3.33)
Understanding TuHURA Biosciences requires distinguishing between market price and book value, where the latter reflects TuHURA's accounting equity. The concept of intrinsic value - what TuHURA Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push TuHURA Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, TuHURA Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.